Outlier in fixed dose combination [Outliers]

posted by yoyo87 – Egypt, 2022-07-21 14:01 (633 d 23:52 ago) – Posting: # 23154
Views: 1,209

Dears

In a BE study of bilayer fixed combination product, one is immediate release and other is sustained, one volunteer in one phase shows no concentrations for the immediate release product (test product) :confused:, while the other sustained active ingredient shows normal concentration profile, all other phases in the volunteer also show regular profile for both actives, no evidence for emesis or any adverse event occurred, what is the probability of this case, could this volunteer be outlier, or its related to the formulation and production? what the suggested solution for this case, that could be accepted by authorities?

Thanks

Complete thread:

UA Flag
Activity
 Admin contact
22,983 posts in 4,822 threads, 1,648 registered users;
30 visitors (0 registered, 30 guests [including 3 identified bots]).
Forum time: 13:54 CEST (Europe/Vienna)

Complex, statistically improbable things are by their nature
more difficult to explain than
simple, statistically probable things.    Richard Dawkins

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5